NeoAntigen Peptides

About BCN Peptides

BCN Peptides is a privately-owned, Barcelona-based Contract Development and Manufacturing Organization (CDMO) focused exclusively on the GMP manufacture of peptides. Founded in 2008, it operates across four core business lines: generic peptides, new chemical entities (NCEs), NeoAntigen peptides for personalized medicine, and cosmetic peptides. The company serves global pharmaceutical markets, is audited by major regulatory bodies like the FDA and EDQM, and positions itself as a customer-oriented partner for peptide drug development from preclinical to commercial stages.

Therapeutic Areas